Logo

OpiCalc

Navigation
FavoritesSpecialtiesGuidelinesMost Used
OpiCalc Logo
FavoritesSpecialtiesGuidelinesMost Used
FavesSpecialtiesGuidelinesMost Used
BPH Impact IndexBosniak ClassificationCAPRA ScoreD'Amico Risk ClassificationEAU NMIBC Risk Groups (2021)EORTC Risk Tables for NMIBCFournier's Gangrene Severity IndexGUPI (Genitourinary Pain Index)Guy's Stone ScoreICIQ-UI SFIGCCCG ClassificationIIEF-5 / SHIMIIQ-7IMDC (Heng) Risk CriteriaIPSS ScoreNIH-CPSIOAB-V8PADUA Prediction ScorePI-RADS v2.1PSA DensityR.E.N.A.L. Nephrometry ScoreResidual Volume (PVR)S.T.O.N.E. NephrolithometrySFU Hydronephrosis GradingUDI-6VUR Grading
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

Non-Custodial
bedside-Ready

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Response time:
Typically < 24 hours.

Clinical Notice:Calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for professional clinical judgment. OpiCalc is an auxiliary reference tool for qualified healthcare professionals.

OpiCalc © 2018-2026

•

All Rights Reserved

Validated • Peer-Reviewed • Instant

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.

Institutional Registry

Urology

PSA kinetics, prostate cancer staging, and stone risk models.

Tool Suite

Validated Registry

Evidence-based
BPH Impact Index
Bosniak Classification
CAPRA Score
D'Amico Risk Classification
EAU NMIBC Risk Groups (2021)
EORTC Risk Tables for NMIBC
Fournier's Gangrene Severity Index
GUPI (Genitourinary Pain Index)
Guy's Stone Score
ICIQ-UI SF
IGCCCG Classification
IIEF-5 / SHIM
IIQ-7
IMDC (Heng) Risk Criteria
IPSS Score
NIH-CPSI
OAB-V8
PADUA Prediction Score
PI-RADS v2.1
PSA Density
R.E.N.A.L. Nephrometry Score
Residual Volume (PVR)
S.T.O.N.E. Nephrolithometry
SFU Hydronephrosis Grading
UDI-6
VUR Grading

About

Urology

Urology tools include prostate cancer risk models, staging for urologic malignancies, and functional scores for lower urinary tract symptoms (IPSS).

Covered Areas

  • Prostate Cancer Risk & Staging
  • Renal Stone Decision Support
  • Urologic Oncology Staging
  • Functional Bladder & Voiding Scores

All tools are based on published clinical evidence. Results should be interpreted alongside individual patient presentation and current institutional guidelines.